Acorda Therapeutics, Inc. (ACOR) financial statements (2020 and earlier)

Company profile

Business Address 420 SAW MILL RIVER ROAD
ARDSLEY, NY 10502
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments253446307159353308
Cash and cash equivalents120294307159153182
Short-term investments134152  200125
Restricted cash and investments010061
Receivables182381523132
Inventory, net of allowances, customer advances and progress billings2729    
Inventory2729    
Prepaid expense121913131616
Deferred tax assets    18
Other current assets4102687
Other undisclosed current assets  38433627
Total current assets:314528442273451409
Noncurrent Assets
Operating lease, right-of-use asset25
Property, plant and equipment1316137344046
Intangible assets, net (including goodwill)4107117171,023614616
Goodwill 282287281184183
Intangible assets, net (excluding goodwill)410429431742431433
Deferred costs  2234
Other noncurrent assets001656
Deferred tax assets, net   2(24)
Other undisclosed noncurrent assets   4 24
Total noncurrent assets:5667727561,070665672
TOTAL ASSETS:8801,3001,1981,3421,1161,081
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities701261271328087
Accounts payable274927271418
Accrued liabilities43771001056656
Employee-related liabilities     13
Debt811701
Business combination, contingent consideration, liability45    
Deferred revenue and credits99938
Other undisclosed current liabilities1097 1(12)
Total current liabilities:9214014414891114
Noncurrent Liabilities
Long-term debt and lease obligation375343334324297290
Long-term debt, excluding current maturities351343334324297290
Operating lease, liability24
Liabilities, other than long-term debt115183155120114112
Deferred revenue and credits23324251
Deferred income tax liabilities3
Liability for uncertainty in income taxes 877  
Other liabilities51212999
Business combination, contingent consideration, liability107163113726453
Other undisclosed noncurrent liabilities 224486  
Total noncurrent liabilities:490547534530411402
Total liabilities:582688678678501517
Stockholders' equity
Stockholders' equity attributable to parent281612520664603540
Common stock000000
Treasury stock, value(1)(2)(0)(0)(0)(0)
Additional paid in capital1,0151,005969921813761
Accumulated other comprehensive income (loss)(1)37(13)(0)(0)
Accumulated deficit(732)(394)(455)(244)(209)(220)
Total stockholders' equity:281612520664603540
Other undisclosed liabilities and equity16   1224
TOTAL LIABILITIES AND EQUITY:8801,3001,1981,3421,1161,081

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues211471588520493402
Revenue, net588520493401
Cost of revenue(70)(144)(162)(117)(92)(80)
Cost of goods and services sold(40)(99)(135)(107)(92)(80)
Gross profit:141327427403400322
Operating expenses(572)(289)(660)(439)(459)(365)
Other undisclosed operating income56   9280
Operating income (loss):(375)38(233)(36)3436
Nonoperating expense(17)(18)(19)(6)(15)(8)
Investment income, nonoperating340001
Other nonoperating income (expense) 0(1)1000
Interest and debt expense(22)(22)(19)(17)(15)(9)
Other undisclosed income from continuing operations before equity method investments, income taxes22221917159
Income (loss) from continuing operations before equity method investments, income taxes:(393)20(252)(42)1928
Other undisclosed income (loss) from continuing operations before income taxes(0)0    
Income (loss) from continuing operations before income taxes:(393)20(252)(42)1928
Income tax expense (benefit)6413297(8)(10)
Net income (loss):(329)34(223)(36)1118
Net income attributable to noncontrolling interest   1  
Net income (loss) available to common stockholders, diluted:(329)34(223)(35)1118

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(329)34(223)(36)1118
Other comprehensive income (loss)(3)(4)20(13)  
Other undisclosed comprehensive loss(1)     
Comprehensive income (loss):(334)30(204)(48)1118
Comprehensive income, net of tax, attributable to noncontrolling interest   0  
Other undisclosed comprehensive loss, net of tax, attributable to parent    (0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(334)30(204)(48)1118

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: